These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32949449)

  • 1. Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19.
    Gallizzi R; Sutera D; Spagnolo A; Bagnato AM; Cannavò SP; Grasso L; Guarneri C; Nunnari G; Mazza F; Pajno GB
    Dermatol Ther; 2020 Nov; 33(6):e14312. PubMed ID: 32949449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study.
    Romita P; Maronese CA; DE Marco A; Balestri R; Belloni Fortina A; Brazzelli V; Colonna C; DI Lernia V; El Hachem M; Fabbrocini G; Foti C; Frasin LA; Guarneri C; Guerriero C; Guida S; Locatelli A; Neri I; Occella C; Offidani A; Oranges T; Pellacani G; Stinco G; Stingeni L; Barbagallo T; Campanati A; Cannavò SP; Caroppo F; Cavalli R; Costantini A; Cucchia R; Diociaiuti A; Filippeschi C; Francomano M; Giancristoforo S; Giuffrida R; Martina E; Monzani NA; Nappa P; Pastorino C; Patrizi A; Peccerillo F; Peris K; Recalcati S; Rizzoli L; Simonetti O; Vastarella M; Virdi A; Marzano AV; Bonamonte D
    Ital J Dermatol Venerol; 2023 Apr; 158(2):117-123. PubMed ID: 37153946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
    El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
    Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
    Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
    Neri I; Virdi A; Corsini I; Guglielmo A; Lazzarotto T; Gabrielli L; Misciali C; Patrizi A; Lanari M
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2630-2635. PubMed ID: 32533899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
    Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
    Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chilblains in children in the setting of COVID-19 pandemic.
    Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
    Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chilblain-Like Lesions (CLL) Coinciding With the SARS-CoV-2 Pandemic in Children: A Systematic Review.
    Starkey SY; Kashetsky N; Lam JM; Dutz J; Mukovozov IM
    J Cutan Med Surg; 2023; 27(3):277-284. PubMed ID: 37340564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.
    Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Takeshita J; French LE; Thiers BH; Hruza GJ; Fox LP;
    J Am Acad Dermatol; 2020 Aug; 83(2):486-492. PubMed ID: 32479979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
    Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
    Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
    Massey PR; Jones KM
    Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema Pernio-Like in Four Adolescents in the Era of the Coronavirus-2 Infection.
    Promenzio L; Arcangeli F; Cortis E; Sama E; Longhini F
    Rev Recent Clin Trials; 2021; 16(2):216-219. PubMed ID: 33069200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
    Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM
    Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID toes: where do we stand with the current evidence?
    Baeck M; Herman A
    Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
    Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
    JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study.
    Robustelli Test E; Sena P; Locatelli AG; Carugno A; di Mercurio M; Moggio E; Gambini DM; Arosio MEG; Callegaro A; Morotti D; Gianatti A; Vezzoli P
    Pediatr Dermatol; 2022 Jan; 39(1):77-83. PubMed ID: 34989043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms.
    Cappel MA; Cappel JA; Wetter DA
    Mayo Clin Proc; 2021 Apr; 96(4):989-1005. PubMed ID: 33714595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "COVID Toes" in Three Siblings.
    Feder HM
    Pediatr Infect Dis J; 2021 Dec; 40(12):e488-e490. PubMed ID: 34292264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.